RXST RxSight, Inc.: Company Short-Term Debts

RxSight, Inc. (RXST) specializes in developing high-tech ophthalmological solutions. The historical price action of a specific short-term debt instrument, which currently stands at 0.00, complements data regarding the world's only lens featuring post-operative light-adjustable vision correction. Through its innovative approach, RxSight, Inc. (RXST) is capturing the premium market, avoiding price wars and steadily expanding its influence.
Metric breakdowns and analytics for RxSight Ophthalmic (RXST)

This indicator determines the volume of obligations due for repayment within the next year to ensure solvency. The trend in the book value of short-term debt allows for the monitoring of covenant breach risks. The current calculated value of 0.00 is derived from the sum of current loans and short-term bonds. An increase in this metric may signal a liquidity shortage, which is critical for RxSight, Inc. (RXST) as it scales sales of adjustable intraocular lenses.